Benjamin schwartz md11/26/2023 ![]() On May 1, 1936, Schwartz was promoted to chief zoologist, the position he held until 1953. He was named assistant chief of the Zoological Division in 1932. He returned to the United States and resumed working at the Zoological Division in 1923, this time as an associate zoologist. Schwartz left the United States in 1920 to accept a teaching post at the University of the Philippines. That same year he discovered the blood-destroying component of the human-borne parasite, Ascaris lumbricoides. Ransom, Schwartz determined the temperature point needed to eradicate the trichinae parasite from pork products. In 1915, Schwartz was appointed as a junior zoologist with the Zoological Division of the Bureau of Animal Industry (BAI). in zoology from George Washington University in 1920. Schwartz then went on to obtain his Ph.D. ![]() ![]() degree from the City College of New York in 1911 and M.A. ![]() He became a naturalized citizen of the United States in 1912. Maybe when they're done chasing Medicare Advantage risk dollars, would-be innovators and disruptors will take notice.Benjamin Schwartz was born on Novemin Austria. Chronic MSK conditions are a huge burden on society, employers, and taxpayers. We are on the verge of an arthritis epidemic. $500 million on Pickleball is the canary in the coal mine. Now is the time to aggressively steer those efforts towards sustainable models. The lessons learned will carry forward to expand beyond surgical episodes. While these efforts have flaws, they showed that it is possible to deliver good outcomes with an eye towards costs. Want value creation? MSK has already danced with VBC programs such as CJR and BPCI. What's better is that this makes the experience better for the doctor and patient. Want margin? MSK lends itself to automation of processes, tight control of logistics and supply lines, predictable unit economics, protocolization, and efficiencies. Want verticals? MSK has them in abundance: office visits, urgent care, physical therapy, imaging, DME, injectables, nutritional supplements, and - if you're ambitious - ASC ownership. As much as I appreciate the work we do, the current patient experience leaves much to be desired. Want to delight MSK patients (customers)? Give them an engaging experience, clear explanation of their condition and treatment options, sensible tech tools, a well-coordinated experience, and evidence-based, high-quality treatment. You could build the One Medical for MSK - except profitable, accessible, well-integrated, and broadly impactful. (Virtual PT is but a small slice and MSK startups seem limited). It continues to surprise me that few seem willing to tackle this opportunity. Unfortunately, Orthopedic Surgeons aren't great at primary care and Primary Care docs aren't great at managing MSK conditions. Yes, that includes primary care - although the line between musculoskeletal health and whole person health is getting blurrier. The opportunity in MSK is, I would argue, greater than in any other area of healthcare (and that's not just Orthopedic Surgeon bias). Whether you think the report is accurate or a gross overestimation, it only scratches the surface of the coming demand for MSK treatment (and the significant associated costs). This story (based on analysis by UBS) raised eyebrows and made the rounds last week. Pickleball costing the American healthcare system $500 million in 2023?
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |